Vibrio vulnificus biotype 1, a causative agent of fatal septicemia or wound infection in humans, is known to produce a toxic metalloprotease as an important virulence determinant. V. vulnificus biotype 2 (serovar E), a primary eel pathogen, was found to elaborate an extracellular metalloprotease that was indistinguishable from that of biotype 1. The potential of V. vulnificus biotype 1 for production of the metalloprotease was compared with biotype 2 and other human non-pathogenic Vibrio species (V.
Introduction
Vibrio vulnificus biotype 1 is a human pathogen causing fatal septicemia or wound infection, and the infection is characterized by formation of hemorrhagic and edematous lesions on the limbs [1] . This bacterium produces a 45-kDa thermolysin-like metalloprotease (V. vulnificus protease [VVP] ) as an important virulence determinant, which increases vascular permeability and causes serious hemorrhagic damage [2, 3] . V. vulnificus biotype 2 that is also named as serovar E [4] is a primary causative agent of epizooticus in eel farms [5, 6] , while it has isolated occasionally from human clinical sources [7] . Our preliminary experiments using partially purified preparations indicated that an extracellular protease produced by biotype 2 might be indistinguishable from VVP. In spite of their being avirulent to humans, other vibrios such as V. anguillarum [8, 9] and V. proteolyticus [10] also produce closely related metalloproteases those exhibit 70-80 % identities in the primary structures and have comparable biological activities. Additionally, these proteolytic enzymes are neutralized with the antibody against VVP [11] .
In various microorganisms, production of extracellular proteases, as well as other factors, is coordinated by the quorum sensing or cell density-dependent regulation system [12, 13] . Two kinds of quorum-sensing systems have been reported in V.
anguillarum.
One system is operated by a small substance, [14] , while another system is linked to a substance related to V. harveyi autoinducer 2 (AI-2) [15] . In V. vulnificus biotype 1, VVP production is positively regulated by the system dependent on the AI-2-like substance [16, 17, 18] . Namely, expression of the vvp gene is augmented at stationary growth phase because of sufficient bacterial multiplication followed by accumulation 4 of the AI-2-like substance.
N-(3-oxodecanoyl)-L-homoserine lactone
The present study showed that V. vulnificus biotype 1 was able to multiply in human plasma. Therefore, although both biotypes have equal capability of producing toxic metalloproteases in vitro, only biotype 1 is capable of growing and therefore secreting the metalloprotease in humans.
Results and Discussion
Extracellular protease produced by biotype 2
For purification of a metalloprotease (E86 protease), the supernatant of the 24-h culture of V. vulnificus E86, a biotype 2 strain, was fractionated by ammonium sulfate precipitation. Thereafter, the preparation was subjected to gel filtration on a HiLoad 26/60 Sephacryl S-200 HR column and hydrophobic interaction chromatography on a HiLoad 10/2 Phenyl Sepharose column. The final preparation thus obtained revealed homogeneity on SDS-PAGE. Namely, in the presence or absence of a reducing agent, a single protein band with a molecular mass of 45-kDa, the same size as VVP from biotype 1, was formed.
The purified E86 protease (1.0 nmol) showed sufficient proteolytic activities toward both azocasein (490 PU) and elastin-Congo red (95 EU), which were very close to those of recombinant VVP (520 PU and 89 EU) used as a positive control. Likewise VVP [2, 3] , E86 protease was inactivated by incubation with phosphoramidon or zincov, the competitive peptide inhibitor for thermolysin-like zinc metalloproteases.
Additionally, in the immunodiffusion test using the IgG antibody against VVP, E86
protease formed a clear precipitation line fused completely with the line to VVP. When injected into a guinea pig skin, it showed the comparable permeability-enhancing and hemorrhagic activity (data not shown).
In order to study genetic identity, PCR amplification using primers for the vvp gene was carried out. As shown in Fig. 1 , the 668-bp product was detected from V.
vulnificus E86, as well as biotype 1 strains. Additionally, a total of 12 V. vulnificus strains including 5 strains in the biotype 2 were tested for PCR amplification. The results revealed that all strains produced the same size amplicon (data not shown).
However, 6 strains from other Vibrio species including V. anguillarum and V.
proteolyticus did not produce the amplicon (data not shown).
Taken together, it may be concluded that an extracellular metalloprotease elaborated by V. vulnificus biotype 2 is closely related to or identical with VVP produced by biotype1.
Bacterial growth and protease production in a complex medium It should be noted that, all vibrios elaborated significant amounts of the metalloprotease only at the stationary phase. These findings strongly suggest that protease production correlates to the bacterial cell density. In fact, the quorum-sensing system has been shown to regulate the protease production [14, 15, 16, 17, 18] . However, in spite of enough multiplication, V. vulnificus and V.
anguillarum showed decreased protease production at 37 o C. Therefore, efficiency of the quorum-sensing system is thought to be dependent on the cultivation conditions.
Our preliminary experiments indicated that secretion of the AI-2-like substance by V.
vulnificus biotype 1 was detected at mid-logarithmic phase and increased several times at stationary phase when cultivated at 25 o C, while its secretion reached maximum around mid-logarithmic phase at 37 o C. Indeed, in Gram-negative bacteria including Escherichia coli, Salmonella enterica serovar Typhimurium and Helicobacter pylori, production of the signal substance operating the quorum-sensing system has been documented to be regulated by metabolic or environmental conditions such as growth phase, pH, and osmolarity [19, 20] .
However, the quorum-sensing system is not a sole regulation mechanism in V.
vulnificus biotype 1. Jeong et al. [21] reported positive regulation of VVP production by cAMP-CRP (cAMP receptor protein) at 30 o C. We also found that the addition of 0.5 % glucose caused remarkable reduction of the extracellular protease activity when V.
vulnificus L-180 was cultivated at 25 o C, suggesting contribution of the cAMP-CRP regulation system (data not shown).
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Bacterial growth and protease production in human serum
Each bacterial strain was inoculated into heat-treated 50 % human serum and incubated at 37 o C with shaking. V. vulnificus L-180 showed significant growth, however, others including V. vulnificus E86 could not multiply even when incubated for 28 h (Fig. 4A) . The cell-free serum sample was collected periodically, and dialyzed against 60 % acetone followed by 0.9 % NaCl to regenerate the proteolytic activity blocked by α-macroglobulin [22] , a broad-spectrum protease inhibitor in human plasma [23] . The sample obtained at 12-h incubation showed a very low, but significant proteolytic activity, while the sample from 28-h incubation revealed much higher proteolytic activity (Fig. 4B) . Since the specific antibody neutralized the activity almost perfectly, the biotype 1 strain was confirmed to produce VVP during incubation in human serum.
Heat-inactivated human serum is known to restrict bacterial growth because of the absence of essential nutrients including free iron [24, 25] . However, the infection caused by V. vulnificus biotype 1 is often associated with patients who have diseases predisposing them to iron overload [26, 27] . The inability of biotype 1 to multiply in human serum in the presence of ethylene diamine di(o-hydroxyphenyl acetic acid), an iron chelator used for removal of free iron, has been documented [28, 29] . However, present study clearly indicated that expression of the iron-assimilating system resulting in sufficient bacterial growth was triggered in human serum if the iron chelator is absent. V. vulnificus biotype 1 synthesizes a phenolate-type siderophore named vulnibactin [30] , which can sequester transferrin-bound iron for growth in human serum. Biosca et al. [31] have reported that a siderophore produced by biotype 8 2 was a hydoxamate-type, not a phenolate-type. The results in Fig.4 may suggest the inability of the hydroxamate-type siderophore to remove iron from human transferrin.
Although it is essential for iron-assimilation, vulnibactin can remove iron only from transferrin digested by VVP [32] . The present study, in which VVP production was observed even at early growth phase, may support our previous conclusion.
VVP-dependence of iron-assimilation in human serum was confirmed by the following experiment. When the VVP-deficient mutant [33] was inoculated into human serum, neither bacterial growth nor VVP production was observed (data not shown).
The virulent potential of V. vulnificus biotype 2 to mice has been reported to be equal to that of biotype1 [34] . We recently found that mouse serum, as well as rabbit serum [28] , contained much free iron and allowed enough bacterial growth [29] . As shown in Fig. 5 , both biotypes revealed sufficient multiplication and protease production when incubated in 50 % rabbit serum. This result suggests that V.
vulnificus biotype 2 also cause systemic infections in individuals whose serum iron levels are extremely increased. Indeed, a few strains isolated from human clinical sources have been identified to be biotype 2 [4, 7] . In contrast to V. vulnificus, V.
anguillarum and V. proteolyticus could not secrete a protease because of negligible multiplication, indicating deficiency of the virulence determinant(s) other than the iron-assimilating system.
Mice were used for evaluation of the virulent potential of V. vulnificus biotype 1.
Using this experimental animal, VVP-null mutants constructed by disruption of the vvp gene revealed full virulence [35, 36] . However, these findings may not lead the conclusion that VVP is not a virulence determinant because biotype 1 administrated to mouse is possible to grow sufficiently without production of VVP.
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The bacterial pathogenicity is determined by invasiveness, resistance to host defense systems, production of virulence factor(s) and others. So far, no virulence determinant specific to V. vulnificus biotype 1 is not known. For instance, both biotypes 1 and 2 can express capsule, which resists to the vibriocidal action of human serum, and can produce cytolytic exotoxin, which may support bacterial invasion.
However, in the present study, biotype 1 showed the distinguished and excellent potential for multiplication and protease production in human serum. This may be one of the important prominences to cause drastic human diseases, such as septicemia accompanied with serious skin lesions. The recombinant VVP was isolated from the periplasmic fraction of a transformant,
Materials and Methods

Protease preparations
Escherichia coli DH5α/pVVP7-1, by ammonium sulfate precipitation followed by column chromatography on a HiLoad 16/10 Phenyl Sepharose column (Amersham Biosciences) as described [37] .
Bacterial growth experiments
V. vulnificus L-180 isolated from human blood [38] , V. vulnificus E86 from a diseased eel [4] , V. anguillarum FY-8701 from a diseased turbot, and V. proteolyticus ATCC 15338 were cultivated in TYE broth supplemented with 2.0 % NaCl at 25 o C for overnight. After cultivation, the bacterial cells were harvested, rinsed twice with 0.9 % NaCl, and inoculated into 2 ml of TYE broth containing 0.9 or 3.0 % NaCl at a cell-density of 1 x 10 7 CFU/ml. Thereafter, the bacteria were cultured at 25 or 37 o C with shaking, and growth was periodically monitored by measuring absorbance at 600 nm.
For studies on bacterial growth in mammalian serum, rabbit or human serum (Chemicon, Temecula, Calif., USA) was heat-treated at 56 o C for 30 min, and the precipitate was removed by centrifugation at 12,000 x g for 30 min. The heat-treated serum was diluted two-fold with 0.9 % NaCl and sterilized by membrane filtration Assay of the proteolytic activity
The protease activity toward azocasein was assayed as described previously [38] .
The sample was allowed to act at 
